Study of the Safety, Tolerability and Efficacy of KPT-8602 in Participants With Relapsed/Refractory Cancer Indications
Karyopharm Therapeutics Inc
Karyopharm Therapeutics Inc
Barbara Ann Karmanos Cancer Institute
National Heart, Lung, and Blood Institute (NHLBI)